Assessing Clinical Disease Recurrence Using Laboratory Data in Surgically Resected Patients From the TOPPIC Trial.
Akbar K WaljeeShirley Cohen-MekelburgYumu LiuBoang LiuJi ZhuPeter D R HigginsPublished in: Crohn's & colitis 360 (2020)
A machine learning algorithm with laboratory data from within the first 3 months postsurgically does not discriminate clinical recurrence well. Alternative noninvasive measures should be considered and further evaluated.
Keyphrases
- machine learning
- end stage renal disease
- big data
- electronic health record
- prognostic factors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- deep learning
- artificial intelligence
- study protocol
- lymph node
- peritoneal dialysis
- randomized controlled trial
- patient reported outcomes
- phase iii
- data analysis
- phase ii